expand_moreexpand_lessexpand_moreexpand_less
|
 |
Michael SmithFinancial Review |
The $2.5 billion sale of Estia Health has put the spotlight on aged care valuations as government funding changes underpin growth. But investors...
The market is focused on a mooted 200 per cent levy on the pharmaceutical giant’s goods. There are far more significant changes afoot at the company.
The state has outlawed private hospitals running acute wards – and the private hospital giant wants to hand over its facility. But no deal is...
login
who are we?
contact us
qosheapp
